Heron Therapeutics Inc (NAS:HRTX)
$ 1.55 -0.05 (-3.13%) Market Cap: 243.35 Mil Enterprise Value: 347.67 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 55/100

Q1 2023 Heron Therapeutics Inc Earnings Call Transcript

May 11, 2023 / 08:30PM GMT
Release Date Price: $2.23 (-8.98%)
Operator

Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Q1 2023 Earnings Conference Call. Before we begin, I would like to remind you that this call will contain forward-looking statements concerning Heron's future expectations, plans, prospects, corporate strategy and performance, which constitute forward-looking statements for the purposes of the safe harbor provision under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in Heron's filings with the SEC.

In addition, any forward-looking statements represent Heron's views only as of the date of this webcast and should not be relied upon as representing Heron's views as of any subsequent date. Heron specifically disclaims any obligations to update such statements. Now I'll turn the call over to Craig.

Craig Alexander Collard
Heron Therapeutics, Inc. - CEO & Director

Thank you, operator. Good

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot